Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8266343rdf:typepubmed:Citationlld:pubmed
pubmed-article:8266343lifeskim:mentionsumls-concept:C1123023lld:lifeskim
pubmed-article:8266343lifeskim:mentionsumls-concept:C0242510lld:lifeskim
pubmed-article:8266343lifeskim:mentionsumls-concept:C0422792lld:lifeskim
pubmed-article:8266343lifeskim:mentionsumls-concept:C1553375lld:lifeskim
pubmed-article:8266343lifeskim:mentionsumls-concept:C0034650lld:lifeskim
pubmed-article:8266343lifeskim:mentionsumls-concept:C0327061lld:lifeskim
pubmed-article:8266343lifeskim:mentionsumls-concept:C1998511lld:lifeskim
pubmed-article:8266343lifeskim:mentionsumls-concept:C0032893lld:lifeskim
pubmed-article:8266343lifeskim:mentionsumls-concept:C1831759lld:lifeskim
pubmed-article:8266343pubmed:issue9lld:pubmed
pubmed-article:8266343pubmed:dateCreated1994-1-25lld:pubmed
pubmed-article:8266343pubmed:abstractTextThe dried skin secretion from Phyllomedusa bicolor, 'sapo', is used by the Matses Indians of the Northern Peru, in shamanic rites mainly designed to improve luck in hunting. When rubbed into burned, exposed areas of the skin, the drug causes the prompt appearance of violent peripheral gastrointestinal and cardiovascular effects soon followed by remarkable central effects (increase in physical strength, heightening of senses, resistance to hunger and thirst, exalted capacity to face stress situations). All the peripheral and most of the central effects of 'sapo' can be ascribed to the exceptionally high content of the drug (up to 7% of its weight) in potently active peptides, easily absorbed through the burned, inflamed areas of the skin. The concentration in 'sapo' of the single peptides (phyllocaerulein, phyllomedusin, phyllokinin, demorphins and deltorphins) has been determined by bioassay, and peptide contents were correlated with the different symptoms of the 'sapo' intoxication.lld:pubmed
pubmed-article:8266343pubmed:languageenglld:pubmed
pubmed-article:8266343pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8266343pubmed:citationSubsetIMlld:pubmed
pubmed-article:8266343pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8266343pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8266343pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8266343pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8266343pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8266343pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8266343pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8266343pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8266343pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8266343pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8266343pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8266343pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8266343pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8266343pubmed:statusMEDLINElld:pubmed
pubmed-article:8266343pubmed:monthSeplld:pubmed
pubmed-article:8266343pubmed:issn0041-0101lld:pubmed
pubmed-article:8266343pubmed:authorpubmed-author:ErspamerVVlld:pubmed
pubmed-article:8266343pubmed:authorpubmed-author:ErspamerG FGFlld:pubmed
pubmed-article:8266343pubmed:authorpubmed-author:BianchiAAlld:pubmed
pubmed-article:8266343pubmed:authorpubmed-author:BarraDDlld:pubmed
pubmed-article:8266343pubmed:authorpubmed-author:SeveriniCClld:pubmed
pubmed-article:8266343pubmed:authorpubmed-author:PotenzaR LRLlld:pubmed
pubmed-article:8266343pubmed:authorpubmed-author:MignognaGGlld:pubmed
pubmed-article:8266343pubmed:issnTypePrintlld:pubmed
pubmed-article:8266343pubmed:volume31lld:pubmed
pubmed-article:8266343pubmed:ownerNLMlld:pubmed
pubmed-article:8266343pubmed:authorsCompleteYlld:pubmed
pubmed-article:8266343pubmed:pagination1099-111lld:pubmed
pubmed-article:8266343pubmed:dateRevised2008-11-21lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:meshHeadingpubmed-meshheading:8266343-...lld:pubmed
pubmed-article:8266343pubmed:year1993lld:pubmed
pubmed-article:8266343pubmed:articleTitlePharmacological studies of 'sapo' from the frog Phyllomedusa bicolor skin: a drug used by the Peruvian Matses Indians in shamanic hunting practices.lld:pubmed
pubmed-article:8266343pubmed:affiliationInstitute of Medical Pharmacology III, University of Rome La Sapienza, Italy.lld:pubmed
pubmed-article:8266343pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8266343pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:8266343pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed